International Journal of Infectious Diseases (Feb 2020)

Analysis of humoral immune responses to recombinant Chlamydia pneumoniae antigens

  • Jürgen Benjamin Hagemann,
  • Ulrike Simnacher,
  • Miriam Theresia Marschall,
  • Julia Maile,
  • Erwin Soutschek,
  • Nele Wellinghausen,
  • Andreas Essig

Journal volume & issue
Vol. 91
pp. 232 – 239

Abstract

Read online

Objectives: Chlamydia pneumoniae is a difficult to diagnose respiratory pathogen. This study was performed to systematically characterize humoral immune responses to selected C. pneumoniae antigens in order to provide novel serodiagnostic perspectives for clinical and epidemiological issues. Methods: Based on a literature search, gene library screening, and serological proteome analysis, 15 immunogenic surface-associated, virulence-associated, and hypothetical C. pneumoniae antigens were selected, recombinantly expressed, and lined on a nitrocellulose strip. Specific IgM and IgG reactivity was measured in a total of 172 PCR- and micro-immunofluorescence testing (MIF)-characterized serum samples from patients with respiratory infections. A theoretical model was conceived to approximate a putative course of C. pneumoniae antigen expression and assess the potential of early and late antigens. Results: While surface antigens performed poorly, the virulence-associated TARP was a reliable antigen for IgM detection, with a sensitivity of 80.0% and a diagnostic specificity of 90.2%. The hypothetical protein YwbM proved powerful for IgG detection with MIF-correlative sensitivities of up to 94.4% and a diagnostic specificity of 95.1%. Conclusions: This study provides new insights into antibody profiles to immunogenic proteins in C. pneumoniae infection. The study findings offer antigen candidates for more reliable and standardized serological investigations of C. pneumoniae infections, including studies on seroprevalence and epidemiology. Keywords: Chlamydia pneumoniae, Serodiagnosis, Line assay, Recombinant antigen